Test could predict which children with T-cell ALL are best candidates for clinical trials
Tuesday, July 20, 2010 - 06:28
in Health & Medicine
A genetic clue uncovered by Dana-Farber Cancer Institute scientists enables doctors to predict, for the first time, which children with T-cell acute lymphoblastic leukaemia (T-ALL) are unlikely to benefit from standard chemotherapy for the disease and should therefore be among the first to receive new treatments in future clinical trials...